Tenon Medical (TNON) Net Income towards Common Stockholders (2021 - 2026)

Tenon Medical's Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at -$6.9 million for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 5.46% year-over-year to -$6.9 million in Q1 2026; TTM through Mar 2026 was -$19.6 million, a 12.44% decrease from a year earlier, with the FY2025 full-year figure at -$16.4 million, up 40.64% from the prior year.
• Net Income towards Common Stockholders retreated to -$6.9 million in Q1 2026 per TNON's latest filing, from -$6.2 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at -$2.4 million in Q1 2022 and bottomed at -$7.9 million in Q4 2022.
• The 5-year median for Net Income towards Common Stockholders is -$3.7 million (2023), against an average of -$4.5 million.
• Across the five-year window, Net Income towards Common Stockholders sank 1076.5% in 2022 and jumped 59.39% in 2023, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$7.9 million in 2022, then soared by 59.39% to -$3.2 million in 2023, then rose by 7.28% to -$3.0 million in 2024, then tumbled by 109.05% to -$6.2 million in 2025, then decreased by 10.36% to -$6.9 million in 2026.
• Per Business Quant, the three latest TNON Net Income towards Common Stockholders figures stand at -$6.9 million (Q1 2026), -$6.2 million (Q4 2025), and -$3.6 million (Q3 2025).